Literature DB >> 17428241

Saturation biopsy for detecting and characterizing prostate cancer.

J Stephen Jones1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17428241     DOI： 10.1111/j.1464-410X.2007.06868.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  22 in total

1.  Prostate cancer: The optimal number and location of cores for repeat biopsy.

Authors:  J Stephen Jones
Journal:  Nat Rev Urol       Date:  2011-10-25       Impact factor: 14.432

2.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

3.  Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.

Authors:  Andre C King; Andrew Livermore; Timo A J Laurila; Wei Huang; David F Jarrard
Journal:  Urol Oncol       Date:  2011-08-03       Impact factor: 3.498

Review 4.  Targeted prostate biopsy and MR-guided therapy for prostate cancer.

Authors:  David A Woodrum; Akira Kawashima; Krzysztof R Gorny; Lance A Mynderse
Journal:  Abdom Radiol (NY)       Date:  2016-05

Review 5.  Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.

Authors:  Jonathan H Wang; Tracy M Downs; E Jason Abel; Kyle A Richards; David F Jarrard
Journal:  Curr Urol Rep       Date:  2017-07       Impact factor: 3.092

6.  Variable correlation of grid coordinates to core location in template prostate biopsy.

Authors:  Christopher M Brede; Nicholas J Douville; Stephen Jones
Journal:  Curr Urol       Date:  2013-02-08

Review 7.  MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer.

Authors:  David A Woodrum; Krzysztof R Gorny; Bernadette Greenwood; Lance A Mynderse
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

Review 8.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

9.  Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.

Authors:  Amit M Algotar; M Suzanne Stratton; Frederick R Ahmann; James Ranger-Moore; Raymond B Nagle; Patricia A Thompson; Elizabeth Slate; Chiu H Hsu; Bruce L Dalkin; Puneet Sindhwani; Michael A Holmes; John A Tuckey; David L Graham; Howard L Parnes; Lawrence C Clark; Steven P Stratton
Journal:  Prostate       Date:  2012-08-10       Impact factor: 4.104

10.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.

Authors:  A V Taira; G S Merrick; R W Galbreath; H Andreini; W Taubenslag; R Curtis; W M Butler; E Adamovich; K E Wallner
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-09-29       Impact factor: 5.554
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.